Albemarle Corporation
Narrative signal
Albemarle Corporation’s revenue growth stands at -44.1% for Dec 2024. Year-over-year, the metric shifted by −75.5 pts, translating into a −240.48% rate of change versus the prior period.
Pair this momentum with product cadence, pricing power, and capital allocation moves to understand durability.
Blend with balance sheet, cash flow, and peer benchmarks from AlphaPilot’s broader dashboards to shape an investable thesis.
Valuation Signals
Track how the market prices earnings, book value, and operating cash flow for rapid context on relative multiples.
Price-to-Earnings Ratio
-8.6x
Price-to-Sales Ratio
1.9x
Price-to-Book Ratio
1x
EV / EBITDA
-12.4x
Dividend Yield
3.1%
Profitability Pulse
Follow margin structure and return ratios that benchmark execution quality and capital efficiency.
Growth Momentum
Gauge the trajectory of revenue, earnings, and free cash flow expansion to understand durability.
Cash & Balance Sheet
Monitor liquidity, leverage, and free cash flow capacity that underpin resilience across cycles.
AlphaPilot quick take
• Albemarle Corporation trades at $127.06 with a market footprint around $15.0B.
• Operating within Basic Materials — Chemicals - Specialty offers instant peer context.
• Dashboard highlight: revenue growth at -44.1%, refreshed from the live fundamentals feed.
• Pivot into AlphaPilot deep dives to benchmark valuation, execution, and resilience.
Company profile
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Albemarle Corporation (ALB) stock FAQs
Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.
What is Albemarle Corporation (ALB) stock price today?
Albemarle Corporation (ALB) trades near $127.06 as of Dec 8, 2025, 8:02 PM. Quotes refresh throughout the trading day in USD via Financial Modeling Prep, which powers the AlphaPilot dashboard.
What is Albemarle Corporation's market capitalization?
Albemarle Corporation's equity is valued around $15.0B, based on the latest share price multiplied by shares outstanding reported to Financial Modeling Prep.
What is the 52-week range for Albemarle Corporation?
Albemarle Corporation's 52-week range runs from $49.43 — $132.90. Comparing the current price to this band helps visualize positioning versus the past year's highs and lows.
How active is trading in Albemarle Corporation stock?
Albemarle Corporation most recently moved about 1.9M shares. Elevated volume often signals strong investor interest or fresh catalysts.
Does Albemarle Corporation pay a dividend?
Albemarle Corporation currently yields roughly 3.1%. Dividend yield divides the last 12 months of payouts by the latest share price, providing a quick income snapshot.
What is Albemarle Corporation's intraday trading range?
Albemarle Corporation has traded between $124.72 — $129.37 so far today. Monitoring the intraday span highlights short-term volatility relative to the longer 52-week range.
Where does the Albemarle Corporation stock data come from?
AlphaPilot sources quotes, fundamentals, and intraday chart data for Albemarle Corporation from the Financial Modeling Prep institutional API. The summary page blends live pricing with fundamentals that refresh after every earnings release or regulatory filing.